Photoreceptor-derived FGF2 mediates a protective stress response without driving pathological retinal neovascularization in ischemic retinopathy
This study identifies endogenous FGF2 as a rod photoreceptor-derived survival factor that protects against ischemic stress without driving pathological retinal neovascularization, thereby distinguishing neuronal adaptation from vascular remodeling in ischemic retinopathy.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Inside the eye, a delicate balance exists between the cells that capture light and the network of blood vessels that feeds them. When the eye suffers from a lack of oxygen, a condition known as ischemia, this balance is threatened. The body attempts to fix the shortage by sending signals to grow new blood vessels, a process called angiogenesis. While this sounds helpful, the new vessels are often fragile and disorganized, leading to vision loss rather than recovery. For decades, scientists have focused on a specific protein called fibroblast growth factor 2, or FGF2, as a primary driver of this dangerous vessel growth. Because adding this protein from the outside causes blood vessels to multiply, it was widely assumed that the body's own production of FGF2 during injury was the main culprit behind the harmful new growth. This assumption has shaped how researchers think about treating retinal diseases, often leading to efforts to block FGF2 to stop the bleeding. However, understanding exactly where this protein comes from inside the eye and what it truly does when the tissue is under stress has remained a mystery.
A team of researchers set out to solve this puzzle by looking directly at the living tissue of the eye during an oxygen-induced injury. Instead of simply adding proteins to a dish, they examined the eye itself, using advanced tools to read the genetic instructions of individual cells. They discovered that the source of the FGF2 protein was not the blood vessels or the supporting cells, but the rod photoreceptors—the cells responsible for seeing in dim light. When these light-sensing cells faced the stress of low oxygen, they began producing FGF2 as part of a coordinated survival plan. This plan also included the production of other stress signals, creating a specific molecular signature that the researchers could track. The team confirmed this finding in a separate model of retinal damage, showing that this response was a consistent reaction of the photoreceptors to injury, not just a one-time event.
The most surprising part of the discovery was what happened next. The researchers found that even as the dangerous new blood vessels began to shrink and disappear, the levels of FGF2 remained high. This timing revealed a clear separation between the eye's attempt to save its nerve cells and its attempt to remodel its blood supply. To test the true purpose of this protein, the scientists created mice that could not produce FGF2 in their photoreceptors. In these animals, the light-sensing cells died much faster when faced with oxygen deprivation, proving that the protein acts as a shield to help the neurons survive the stress. Yet, when the researchers looked at the blood vessels, they found no difference. Whether the protein was missing or present in extra amounts, the growth and regression of the abnormal vessels proceeded exactly as they did in normal eyes. This result directly challenges the long-held belief that FGF2 is the engine driving the pathological vessel growth in this type of injury.
The study suggests that the eye uses FGF2 for a very different job than previously thought. While other signals, such as VEGF, are known to strongly encourage blood vessels to grow, the receptors for FGF2 are scarce on the surface of those vessels. This lack of receptors provides a physical reason why FGF2 can help the nerve cells survive without triggering the chaotic growth of new blood vessels. The findings indicate that the eye's response to injury is not a single, unified reaction but a collection of distinct strategies. One strategy focuses on keeping the light-sensing cells alive, while another manages the blood supply, and these two processes can operate independently. By identifying FGF2 as a protective factor for neurons rather than a driver of disease, the research offers a clearer picture of how the eye copes with injury, suggesting that blocking this protein might not be the right path for treating retinal vascular diseases.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.